Observational studyRespiratory research2020
Extracorporeal membrane oxygenation as a bridge to lung transplantation: analysis of Korean organ transplantation registry (KOTRY) data.
Observational study in Respiratory research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- Impact of pre-transplant veno-venous extracorporeal membrane oxygenation on post-lung transplant infections.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025Article
- SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient.Nature communications · 2025Article
- [Extracorporeal Life Support in Lung Transplantation and Beyond].Zentralblatt fur Chirurgie · 2025Review
- Enhancing lung transplantation with ECMO: a comprehensive review of mechanisms, outcomes, and future considerations.The journal of extra-corporeal technology · 2024Review
- Risk factors and prognostic modeling in bridging extracorporeal membrane oxygenation patients before lung transplantation.Journal of thoracic disease · 2024Article
- Worth a Double Take? An In-Depth Review of Lung Retransplantation.Journal of clinical medicine · 2023Review
- Extracorporeal life support as a bridge to lung transplantation: a narrative review.Journal of thoracic disease · 2023Review
- Critical Care Management Following Lung Transplantation.Journal of chest surgery · 2022Article
- Awakening in extracorporeal membrane oxygenation as a bridge to lung transplantation.Acute and critical care · 2022Article
- Extracorporeal membrane oxygenation support for lung transplantation: Initial experience in a single center in China and a literature review.Frontiers in medicine · 2022Article
- Extracorporeal membrane oxygenation in lung transplantation: Indications, techniques and results.World journal of transplantation · 2021Review
- Extracorporeal membrane oxygenation and lung transplantation.Indian journal of thoracic and cardiovascular surgery · 2021Article
- Effects of the duration of bridge to lung transplantation with extracorporeal membrane oxygenation.PloS one · 2021Article
- Lung transplantation for severe COVID-19-related ARDS.Therapeutic advances in respiratory diseaseObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundThe use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation has greatly increased. However, data regarding the clinical outcomes of this approach are lacking. The objective of this multicenter prospective observational cohort study was to evaluate lung transplantation outcomes in Korean Organ Transplantation Registry (KOTRY) patients for whom ECMO was used as a bridge to transplantation.
methodsBetween March 2015 and December 2017, a total of 112 patients received lung transplantation and were registered in the KOTRY, which is a prospective, multicenter cohort registry. The entire cohort was divided into two groups: the control group (n = 85, 75.9%) and bridge-ECMO group (n = 27, 24.1%).
resultsThere were no significant differences in pre-transplant and intraoperative characteristics except for poorer oxygenation, more ventilator use, and longer operation time in the bridge-ECMO group. The prevalence of primary graft dysfunction at 0, 24, 48, and 72 h after transplantation did not differ between the two groups. Although postoperative hospital stays were longer in the bridge-ECMO group than in the control group, hospital mortality did not differ between the two groups (25.9% vs. 13.3%, P = 0.212). The majority of patients (70.4% of the bridge-ECMO group and 77.6% of the control group) were discharged directly to their homes. Finally, the use of ECMO as a bridge to lung transplantation did not significantly affect overall survival and graft function.
conclusionsShort- and long-term post-transplant outcomes of bridge-ECMO patients were comparable to recipients who did not receive ECMO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.